US Executive Compensation Proxy SEC Filings — April 20, 2026

20-04-2026

Barrett Business Services, Inc. (BBSI) seeks shareholder approval for the Second Amended and Restated 2020 Stock Incentive Plan, increasing authorized shares from 2,900,000 to 4,100,000 (adding 1,200,000 shares, or 4.9% of outstanding shares as of April 6, 2026), with only 456,443 shares currently available for future grants. The plan maintains the ISO limit at 1,500,000 shares and includes features like no liberal share counting and minimum vesting requirements. All directors and executives comply with stock ownership guidelines, Section 16 reporting for 2025, and no insiders hold pledged shares.

• ·Non-employee directors expected to own shares worth at least 3x annual retainer ($70,000) within 3 years of election.
• ·Executive officers expected to own shares/RSUs worth at least 3x annual base salary by July 1, 2021 or 5 years after appointment.
• ·Plan terminates May 27, 2030; awards include ISOs, nonqualified options, SARs, RSUs, PSUs (no SARs or Restricted Shares granted to date).
• ·No repricing, minimum 1-year vesting (5% carve-out up to 205,000 shares), no dividends on unvested awards, 10-year max term.

20-04-2026

Galera Therapeutics' DEF 14A proxy statement solicits votes for its combined 2025-2026 annual meeting on May 8, 2026, including director elections (J. Mel Sorensen as Class III, Nancy Chang and Michael Friedman as Class I), advisory ratification of KPMG LLP as auditors, say-on-pay approval and frequency (recommends annually), and charter amendments to double authorized common stock to 400 million shares, permit written consents, and authorize a discretionary reverse stock split (1:75 to 1:200). On April 14, 2026, the company entered an all-stock merger agreement with Obsidian Therapeutics to form a combined entity listing as OBX on Nasdaq, backed by a $350M private placement commitment funding into H2 2028 and CVRs for pre-closing Galera stockholders, with support agreements from holders of 51.1% of outstanding capital stock. While the merger and financing provide growth runway through key 2027 milestones, the proposed reverse stock split signals potential share price concerns.

• ·Annual meeting is virtual via www.virtualshareholdermeeting.com/GRTX2026.
• ·Reverse stock split ratio range: 1:75 to 1:200, if and when determined by Board.
• ·Merger expected to list combined company on Nasdaq under ticker 'OBX'.
• ·Proxy materials distributed on or about April 20, 2026.

20-04-2026

Bright Horizons Family Solutions Inc. (BFAM) filed its DEF 14A Proxy Statement on April 20, 2026, for the virtual 2026 Annual Meeting of Shareholders on June 3, 2026, at 8:00 a.m. ET. Shareholders of record as of April 8, 2026, will vote on electing six director nominees for one-year terms, approving on an advisory basis the 2025 compensation paid to named executive officers, and ratifying Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• ·Virtual meeting accessible at www.virtualshareholdermeeting.com/BFAM2026; requires 16-digit control number for admission.
• ·Proxy materials and 2025 Annual Report on Form 10-K available at www.proxyvote.com or investors.brighthorizons.com.
• ·Includes sections on director nominees, executive compensation (including Pay versus Performance), audit matters, and corporate governance.

20-04-2026

ClimateRock, a blank check company, is convening an extraordinary general meeting on May 1, 2026, to approve the Fifth Extension Amendment Proposal, extending the business combination deadline from May 2, 2026, to November 2, 2026, to facilitate the ongoing GreenRock Business Combination. The Adjournment Proposal allows for further solicitation if needed. Without extension approval, the company faces liquidation risk, ceasing operations and redeeming public shares.

• ·Record Date: April 10, 2026
• ·Meeting location: 1345 Avenue of the Americas, 11th Floor, New York, New York 10105
• ·Previous extensions: From May 2, 2023 (initial 12 months post-IPO on May 2, 2022) through paid extensions to November 2, 2023; then to May 2, 2024; May 2, 2025; November 2, 2025; and May 2, 2026
• ·Fifth Extension Amendment requires 2/3 affirmative vote; Adjournment requires simple majority
• ·Public shareholders may redeem shares in connection with the extension regardless of vote

20-04-2026

ACI Worldwide, Inc. (ACIW) filed its DEF 14A Proxy Statement on April 20, 2026, for the 2026 Annual Meeting of Stockholders on June 2, 2026, via virtual audio webcast, with a record date of April 8, 2026. Stockholders are asked to vote on electing nine directors to serve until the 2027 meeting, ratifying Deloitte & Touche LLP as the independent registered public accounting firm for 2026, and an advisory vote to approve named executive officer compensation. The statement outlines corporate governance, director nominees, compensation discussions, and references to 2025 executive compensation tables without specific performance metrics in the provided content.

• ·Annual Meeting: June 2, 2026, 10:00 a.m. ET, virtual live audio-only webcast at www.proxydocs.com/ACIW (advance registration required)
• ·Record Date: Close of business on April 8, 2026
• ·Company headquarters: 6060 Coventry Drive, Elkhorn, NE 68022
• ·References to 2025 compensation disclosures for executives including Mr. Behrens, Mr. Silva, and Mr. Kuruvilla
• ·Equity compensation plan information and pay versus performance disclosures included

20-04-2026

Ceribell, Inc. (CBLL) filed its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders, to be held virtually on June 2, 2026, at 9:00 a.m. PT, with a record date of April 6, 2026. Shareholders are asked to vote on Proposal 1: election of two director nominees to serve until the 2029 annual meeting; and Proposal 2: ratification of PricewaterhouseCoopers LLP as independent auditors for the year ending December 31, 2026. As of the record date, 37,872,491 shares of common stock were outstanding.

• ·Annual Meeting accessible at www.virtualshareholdermeeting.com/CBLL2026 using 16-digit control number.
• ·Proposal 1 requires plurality vote; Proposal 2 requires majority of votes cast (excluding abstentions/broker non-votes).
• ·Proposal 1 is non-routine (broker non-votes possible); Proposal 2 is routine.

20-04-2026

This DEF 14A proxy statement solicits votes for the Joint Annual Meeting of Shareholders of nine Virtus closed-end funds, including Virtus Artificial Intelligence & Technology Opportunities Fund (AIO), held virtually on June 1, 2026 at 3:30 p.m. ET. Proposals include electing multiple Class I, II, and III trustees/directors specific to each fund (e.g., Donald C. Burke, R. Keith Walton, and Brian T. Zino for AIO) and ratifying PricewaterhouseCoopers LLP as independent auditor for each fund. The Boards, including independent trustees, unanimously recommend voting 'FOR' all nominees and the ratification.

• ·Record date for shareholders entitled to vote: close of business on March 31, 2026
• ·Virtual meeting access: www.meetnow.global/MN6WL79 (control number from proxy card required)
• ·Proxy materials first mailed: on or about April 20, 2026
• ·Advance registration deadline for beneficial owners: 5:00 p.m. ET on May 27, 2026 (email legal proxy to shareholdermeetings@computershare.com)

20-04-2026

Bain Capital Private Credit, a BDC, has filed a DEF 14A proxy statement for its 2026 Annual Meeting of Shareholders on May 21, 2026 (virtual via live webcast), seeking to elect three Class I Trustees for a three-year term and ratify PricewaterhouseCoopers LLP as independent auditor for the fiscal year ending December 31, 2026. The Board unanimously recommends voting 'FOR' both proposals. As of the record date April 10, 2026, 40,474,691 common shares were outstanding, requiring a quorum of at least 20,237,345.50 shares.

• ·Annual Meeting at 3:00 p.m. Eastern Time, fully virtual; registration required at www.proxydocs.com/BCPrivateCredit.
• ·Trustee Proposal requires plurality vote; Auditor Proposal is routine (broker discretionary).
• ·No other matters expected; no dissenters' or appraisal rights.
• ·Proxy solicitation costs borne by the Company.

20-04-2026

DoorDash, Inc.'s 2026 definitive proxy statement solicits votes for the virtual annual stockholder meeting on June 10, 2026 at 10:00 a.m. PT, with record date April 15, 2026, for electing four Class III directors until 2029, ratifying KPMG LLP as independent auditors for fiscal year ending December 31, 2026, and approving named executive officer compensation on an advisory basis. The board recommends voting FOR all proposals, with no reported controversies or declines in governance metrics. Tony Xu, Co-Founder, CEO, and Chair, signed the notice.

• ·Annual Meeting location: virtually via live audio webcast at www.virtualshareholdermeeting.com/DASH2026
• ·Voting control number: 16-digit control number required for virtual attendance and voting
• ·Fiscal year for auditor ratification: ending December 31, 2026
• ·Director terms: Class III directors to serve until 2029 annual meeting

20-04-2026

Exponent, Inc. filed its definitive DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on June 4, 2026 at 8:00 a.m. Pacific time. Key agenda items include electing six directors for one-year terms, ratifying KPMG LLP as independent registered public accounting firm for the fiscal year ending January 1, 2027, and an advisory vote to approve fiscal 2025 named executive officer compensation. The record date for voting eligibility is April 8, 2026.

• ·Virtual meeting access: meetnow.global/MGTD45N
• ·Advance registration deadline for beneficial owners: 5:00 p.m. Eastern Time on June 1, 2026
• ·Proposal No. 2 (auditor ratification) is a routine matter allowing broker discretionary voting
• ·Includes Pay Versus Performance Disclosure for 2025 and CEO Pay Ratio

20-04-2026

Larimar Therapeutics' 2026 Proxy Statement seeks stockholder approval for electing three Class III directors (Frank Thomas, Carole S. Ben-Maimon, M.D., Joseph Truitt), advisory approval of NEO compensation (annually), ratification of PwC as 2026 auditor, and amending the certificate to increase authorized common shares from 115,000,000 to 215,000,000. Recent highlights include FDA Breakthrough Therapy Designation for nomlabofusp in February 2026, positive long-term study data in September 2025, and capital raises via public offerings netting $65.0 million (July 2025) and $107.6 million (February 2026). The company maintains strong governance with a 6-member board, 5 independent directors, and an independent chairperson.

• ·Annual Meeting: May 19, 2026 at 8:00 a.m. ET, virtual via meetnow.global/MWXPCMG
• ·Record Date: March 25, 2026
• ·Board: 5 independent directors out of 6, independent chairperson
• ·Class III directors serve three-year term expiring at 2029 Annual Meeting

20-04-2026

United States Antimony Corporation (USAC) is soliciting proxies for its 2026 Annual Meeting of Shareholders on June 12, 2026, held virtually, to elect seven directors, approve an amendment to increase authorized shares, and ratify Assure CPA, LLC as independent auditors for FY 2026. The record date is April 15, 2026, with 143,078,275 common shares and 177,904 Series C preferred shares outstanding and entitled to vote. No other matters are anticipated.

• ·Meeting quorum requires majority of voting shares present in person or by proxy.
• ·Directors elected by plurality vote; Proposals 2 and 3 by majority of votes cast.
• ·Voting deadline: 11:59 p.m. ET on June 11, 2026 via internet or phone.
• ·2025 Annual Report on Form 10-K available at www.proxyvote.com, www.usantimony.com/investors, or SEC website.

20-04-2026

NovoCure Limited's DEF 14A proxy statement, filed April 20, 2026, outlines the Annual General Meeting on June 3, 2026, for electing 11 directors to one-year terms, ratifying Kost Forer Gabbay & Kasierer (EY Global) as auditor for FY ending December 31, 2026, a non-binding advisory vote on executive compensation, and approving an amendment to the 2024 Omnibus Incentive Plan to increase available ordinary shares. The record date is April 6, 2026, and the Board recommends voting FOR all proposals. No specific compensation figures or performance metrics are detailed in the provided content.

• ·Annual Meeting location: Second Floor, No. 4 The Forum, Grenville Street, St. Helier, Jersey, Channel Islands JE2 4UF at 9:00 a.m. ET
• ·Shareholders of record as of April 6, 2026 (Record Date) eligible to vote
• ·Proxy materials available via www.proxyvote.com; Notice of Internet Availability sent on or about April 20, 2026

20-04-2026

ALX Oncology Holdings Inc. issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders on June 10, 2026 (virtual format), seeking shareholder approval to elect three Class III directors (Daniel Curran, M.D., Rekha Hemrajani, and Chris Takimoto, M.D., Ph.D., F.A.C.P.) to serve until 2029, an advisory vote to approve named executive officer compensation, and ratification of KPMG LLP as independent auditors for FY 2026. The record date is April 15, 2026, with 134,559,917 shares of common stock outstanding. No financial performance metrics or period-over-period comparisons are detailed in the filing.

• ·Annual Meeting: June 10, 2026 at 1:00 p.m. Pacific Time, virtual via www.virtualshareholdermeeting.com/ALXO2026
• ·Record date: April 15, 2026
• ·Proxy materials available on or about April 20, 2026 via investor relations website https://ir.alxoncology.com/
• ·Board recommends FOR all three proposals

20-04-2026

Aura Biosciences, Inc. will hold its 2026 Annual Meeting of Stockholders virtually on June 11, 2026 at 9:30 a.m. ET to elect two Class II directors to serve until the 2029 annual meeting and to ratify Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. Stockholders of record as of the close of business on April 15, 2026, when 64,199,778 shares of common stock were outstanding, are entitled to vote. The company is utilizing the SEC's Notice and Access model, mailing notices on or about April 20, 2026, with proxy materials available online.

• ·Virtual meeting access: www.virtualshareholdermeeting.com/AURA2026 (requires 16-digit control number)
• ·Proxy materials and 2025 Annual Report available at www.ProxyVote.com/ and www.sec.gov
• ·Company is an emerging growth company under JOBS Act; initial public offering in November 2021

20-04-2026

Nextdoor Holdings, Inc. filed its 2026 Proxy Statement for the virtual Annual Meeting on June 9, 2026, seeking stockholder approval to elect David Sze as Class II director, ratify Ernst & Young LLP as auditors for 2026, and approve NEO compensation on an advisory basis. Key 2025 highlights include revenue of $258M, up $10.4M or 4% YoY from 2024, 21.0M Platform WAU, over 105M Verified Neighbors across 350K+ neighborhoods, and $404.8M in cash equivalents. The company launched a new Nextdoor initiative enhancing the platform with AI-driven content personalization.

• ·Annual Meeting: June 9, 2026 at 9:00 a.m. PT / 12:00 p.m. ET, virtual at www.virtualshareholdermeeting.com/NXDR2026
• ·Record Date: April 13, 2026
• ·Operates in over 350,000 neighborhoods across 11 countries

20-04-2026

Calumet, Inc.'s 2026 Proxy Statement outlines the June 2, 2026 virtual annual meeting for electing three Class II directors, advisory approval of executive compensation, and ratification of Grant Thornton LLP as auditors. FY2025 financial highlights include a net loss of $33.8 million but Adjusted EBITDA with Tax Attributes up 28% YoY to $293.3 million on $4.1 billion revenue, with debt reduction over $220 million and a $1.44 billion DOE loan for Montana Renewables; however, Performance Brands Adjusted EBITDA was nearly flat YoY despite net income growth, impacted by the Royal Purple industrial divestiture and non-recurring prior insurance proceeds.

• ·Annual Meeting: June 2, 2026, 9:00 a.m. ET, virtual at www.virtualshareholdermeeting.com/CLMT2026
• ·Record date: April 6, 2026
• ·Montana Renewables MaxSAF 150 expansion expected to deliver 120 to 150 million gallons annual SAF production
• ·Montana Renewables initial capex estimate for MaxSAF step was $150 million to $250 million, revised lower

20-04-2026

Saga Communications, Inc. has issued a proxy statement for its 2026 Annual Meeting of Shareholders, to be held virtually on June 1, 2026, with a record date of April 6, 2026, for electing seven directors (noting the retirement of Timothy J. Clarke), ratifying Crowe LLP as independent auditors for the fiscal year ending December 31, 2026, and an advisory 'Say on Pay' vote on named executive officer compensation. As of the record date, 6,363,968 shares of Class A Common Stock are issued and outstanding, entitled to vote as a single class. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Board size reducing from eight to seven directors effective at the Annual Meeting.
• ·Voting quorum requires holders of a majority of issued and outstanding Class A Common Stock present in person or by proxy.
• ·Directors elected by plurality vote; Proposals 2 and 3 require majority of shares entitled to vote present.
• ·Proxy materials available via Internet Availability Notice sent on or about April 20, 2026; 2025 Annual Report accessible online.

20-04-2026

Torrid Holdings Inc. (CURV) filed its DEF 14A proxy statement for the 2026 Annual Meeting on June 2, 2026, at its headquarters in City of Industry, CA, proposing the election of two Class II directors (Theophlius Killion and Michael A. Shaffer) to serve until 2029, advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditors for the fiscal year ending January 30, 2027. The record date is April 13, 2026, with 99,498,475 shares of common stock outstanding entitled to vote. No financial performance metrics or period-over-period comparisons are detailed in the filing.

• ·Annual Meeting location: 18501 East San Jose Avenue, City of Industry, California 91748
• ·Proxy submission deadline: 11:59 p.m. EDT on June 1, 2026 (Internet/phone)
• ·Employee Stock Purchase Plan proxy deadline: 11:59 p.m. EDT on May 30, 2026
• ·Fiscal 2025 Annual Report on Form 10-K available at https://investors.torrid.com

20-04-2026

MetroCity Bankshares, Inc. (MCBS) filed its DEF 14A proxy statement dated April 20, 2026, for the annual shareholder meeting on May 21, 2026, at 4:00 p.m. ET at Metro City Bank's main office in Doraville, Georgia. Shareholders will vote to elect four Class II directors for three-year terms expiring in 2029 and one new Class I director for a two-year term expiring in 2028, and to ratify Crowe LLP as the independent registered public accounting firm for the year ending December 31, 2026. The record date is April 10, 2026, with the board unanimously recommending votes 'FOR' all proposals.

• ·Record date: April 10, 2026; only shareholders of record entitled to notice and vote.
• ·Meeting location: 5114 Buford Highway, Doraville, Georgia 30340.
• ·Proxy materials available at www.edocumentview.com/MCBS.
• ·Includes sections on corporate governance, executive and director compensation, audit committee report, and stock ownership.

20-04-2026

FTAI Infrastructure Inc. (FIP) has issued a proxy statement for its 2026 Annual Meeting of Shareholders on May 29, 2026, at 9:00 a.m. ET, seeking approval to elect one Class I director to serve until the 2029 annual meeting and to ratify the appointment of KPMG LLP as independent registered public accounting firm for fiscal year 2026. The record date is April 1, 2026, with 118,163,555 shares of Common Stock outstanding entitled to vote. No financial performance metrics or period-over-period comparisons are provided in the filing.

• ·Annual Meeting location: One Manhattan West, New York, New York 10001.
• ·Executive office address: 1345 Avenue of the Americas, 45th Floor, New York, New York 10105.
• ·Voting quorum requires majority of outstanding shares present in person or by proxy.
• ·Director election requires plurality of votes cast; auditor ratification requires majority of votes present and entitled to vote.
• ·Proxy materials first mailed on or about April 20, 2026.

20-04-2026

CVRx, Inc. (CVRX) has filed a DEF 14A proxy statement for its virtual Annual Meeting on June 1, 2026, at 10:00 a.m. Central Time, where shareholders will vote on electing three Class II directors to serve until the 2029 annual meeting and ratifying Grant Thornton LLP as the independent auditor for the fiscal year ending December 31, 2026. The Record Date is April 6, 2026, with 26,430,915 shares of common stock outstanding, requiring a quorum of at least 13,215,458 shares; the Board recommends voting 'For' both proposals.

• ·Virtual meeting access via www.virtualshareholdermeeting.com/CVRX2026 with 16-digit control number required.
• ·Stockholder proposals for 2027 Annual Meeting under Rule 14a-8 due by December 21, 2026; other nominations/proposals due between February 1, 2027 and March 3, 2027.
• ·Corporate address: 9201 West Broadway, Suite 650, Minneapolis, Minnesota 55445.

20-04-2026

Granite Point Mortgage Trust Inc., a REIT focused on commercial mortgage loans, is holding its annual meeting on June 4, 2026, to elect seven director nominees, approve executive compensation on an advisory basis, and ratify Ernst & Young LLP as auditor for the fiscal year ending December 31, 2026. The 2025 'Say on Pay' vote received only 69% approval, below historical levels, leading to investor outreach with 20-30 top institutional investors and program changes including no future off-cycle equity awards and revised long-term incentives. Corporate governance remains strong with an independent Chair, majority voting for directors, and robust committee oversight, though no financial performance metrics are detailed.

• ·Record date: April 6, 2026
• ·Virtual meeting URL: virtualshareholdermeeting.com/GPMT2026
• ·Director stock ownership guideline: 3x annual cash retainer for independents
• ·Director commitment limit: no more than 3 other public company boards (1 for CEOs)
• ·Internalized management on December 31, 2020, from Pine River Capital Management L.P.

20-04-2026

Smithfield Foods, Inc. (SFD) filed its DEF 14A proxy statement on April 20, 2026, for the virtual 2026 Annual Meeting of Shareholders on June 2, 2026, at 8:00 a.m. ET. Key proposals include electing Class II directors Long Wan, Hank Shenghua He, and Raymond A. Starling to serve until the 2029 Annual Meeting, ratifying Ernst & Young LLP as independent auditor for the fiscal year ending January 2, 2027, and an advisory vote to approve named executive officer compensation for fiscal 2025. As of the record date April 8, 2026, 393,477,263 shares of common stock were outstanding.

• ·Annual Meeting accessible virtually at www.virtualshareholdermeeting.com/SFD2026; online check-in begins at 7:45 a.m. ET.
• ·Proxy materials first made available to shareholders on or about April 20, 2026.
• ·References annual report on Form 10-K for fiscal year ended December 28, 2025.

20-04-2026

Standard Premium Finance Holdings, Inc. disclosed multiple changes in its independent registered public accounting firms: Assurance Dimensions, LLC resigned on April 18, 2025 and was replaced by Stephano Slack, LLC on April 21, 2025; Stephano Slack, LLC resigned on March 27, 2026 and was replaced by M&K CPAs, PLLC on March 30, 2026, with no disagreements, adverse opinions, or reportable events noted. Insiders and directors as a group beneficially own 48.6% of common stock, led by CEO William Koppelmann at 25.1%, indicating strong alignment but also concentrated control.

• ·Ownership data as of April 13, 2026.
• ·Annual meeting scheduled for June 12, 2026.
• ·Audit Committee members: Scott Howell, MD; Mark Kutner, MD; Carl C. Hoechner.
• ·No consultations with M&K CPAs, PLLC prior to engagement regarding accounting issues.

20-04-2026

Bain Capital Specialty Finance, Inc. (BCSF) has filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on May 21, 2026, at 2:30 p.m. ET, with a record date of April 10, 2026. The meeting includes two proposals: electing three Class I Directors for a three-year term expiring in 2029 and ratifying PricewaterhouseCoopers LLP as the independent auditor for the fiscal year ending December 31, 2026; the Board unanimously recommends voting 'FOR' both. As of the record date, 64,868,506.64 shares of common stock were outstanding, requiring a quorum of at least 21,622,835.55 shares.

• ·Annual Meeting is completely virtual via live webcast; registration required at www.proxydocs.com/BCSF.
• ·Director Proposal is non-routine (broker non-votes not counted); Auditor Proposal is routine.
• ·No other matters expected to come before the meeting; no dissenters’ or appraisal rights.

20-04-2026

Verrica Pharmaceuticals Inc. (VRCA) filed a DEF 14A proxy statement on April 20, 2026, seeking stockholder approval for the election of two Class II directors, Paul B. Manning and Lawrence Eichenfield, to serve three-year terms expiring at the 2029 annual meeting; the Board currently has eight members divided into three classes. Nominees were previously elected by stockholders, and directors are elected by plurality vote with no noted controversies or declines in attendance (three of the then-serving directors attended the 2025 Annual Meeting). The statement includes XBRL tags referencing equity compensation metrics for executives including Jayson Rieger and Ted White across 2023-2025, but no specific values are provided.

• ·Board vacancies filled only by majority vote of remaining directors.
• ·Directors elected by plurality of votes from shares present or by proxy.
• ·Nominating and Corporate Governance Committee evaluates nominees for balance of skills, integrity, and industry expertise.
• ·Annual Meeting attendance policy encourages but does not require director participation.

20-04-2026

Immuneering Corporation (IMRX) has filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders, to be held virtually on June 11, 2026 at 11:00 a.m. ET via www.virtualshareholdermeeting.com/IMRX2026. Shareholders of record as of April 15, 2026 (64,697,227 shares of Class A common stock outstanding) will vote on electing Peter Feinberg and Laurie B. Keating as Class II directors for terms expiring in 2029 and ratifying RSM US LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. No other matters are anticipated, and a quorum requires a majority in voting power present or by proxy.

• ·Proxy materials first sent on or about April 20, 2026; voting deadline 11:59 p.m. ET on June 10, 2026 for phone/internet/mail.
• ·Proposal 1 (director election) is non-discretionary (broker non-votes possible); Proposal 2 (auditor ratification) is discretionary.
• ·Stockholder list available for examination by emailing mbookman@immuneering.com with proof of ownership, up to 10 days before meeting.

20-04-2026

Asana, Inc.'s DEF 14A proxy statement for the 2026 annual stockholder meeting on June 8, 2026 (virtual at 2:00 p.m. PT) seeks votes to elect three Class III directors (Krista Anderson-Copperman, Sydney Carey, Dan Rogers) to serve until 2029, ratify PricewaterhouseCoopers LLP as independent auditor for fiscal year ending January 31, 2027, and approve on an advisory basis the compensation of named executive officers. The record date is April 13, 2026. No financial performance metrics, period-over-period changes, or compensation amounts are detailed in the provided filing content.

• ·Fiscal year periods referenced: FY2026 (2025-02-01 to 2026-01-31)
• ·Voting deadline: 11:59 p.m. ET on June 7, 2026 via internet/phone
• ·Board recommends FOR all three proposals

20-04-2026

GPGI, Inc., currently incorporated in Delaware, is seeking stockholder approval via a special meeting for reincorporation to Nevada under a Plan of Conversion, effective on or about June 5, 2026, to benefit from a statute-focused legal environment, codified fiduciary duties, and potentially reduced litigation risks. The move will not alter headquarters, business operations, management, employees, assets, liabilities, or NYSE trading under symbol 'GPGI', with shares converting 1:1. However, it introduces differences in stockholder rights, including stricter books and records inspection thresholds (5-15% ownership vs. Delaware's broader access) and permissions for directors to consider non-stockholder interests, potentially limiting certain current rights.

• ·Board unanimously approved Nevada Reincorporation on April 3, 2026
• ·Outside counsel review conducted in December 2025 and March 2026
• ·Nevada Combinations Statutes (NRS 78.411 to 78.444) apply if company becomes resident domestic corporation
• ·Stockholder contacts: Innisfree M&A (1-877-800-5186) or GPGI Corporate Secretary (908-518-0500)

20-04-2026

Gates Industrial Corporation plc (GTES) filed its DEF 14A proxy statement on April 20, 2026, for the 2026 Annual General Meeting (AGM) to be held virtually on June 4, 2026, at 10:00 a.m. Mountain Time. Shareholders of record as of April 7, 2026, with 254,585,738 ordinary shares outstanding, will vote on electing eight directors, advisory votes on NEO compensation and Directors’ Remuneration Report, ratification of Deloitte & Touche LLP as independent auditor for fiscal 2026, re-appointment of Deloitte LLP as U.K. statutory auditor, and Board authorizations to allot equity securities (with and without pre-emptive rights). No financial performance metrics are detailed in the proxy.

• ·AGM conducted solely via live webcast at www.virtualshareholdermeeting.com/GTES2026; no physical location.
• ·Ordinary resolutions (1-7): elect directors, advisory NEO compensation, advisory Directors’ Remuneration Report (Appendix A), ratify Deloitte & Touche LLP for fiscal 2026, re-appoint Deloitte LLP as U.K. auditor until next AGM, authorize Audit Committee to set Deloitte LLP remuneration, authorize Board to allot equity securities.
• ·Special resolution (8): authorize Board to allot equity securities without pre-emptive rights, subject to Proposal 7.
• ·Quorum requires majority of voting rights; ordinary resolutions need simple majority of votes cast.

20-04-2026

General Motors Co (GM) filed its DEF 14A Proxy Statement on April 20, 2026, focusing on pay versus performance disclosures. The filing structures data via XBRL tags for Principal Executive Officer (PEO) and Non-PEO Named Executive Officers (NEOs) across fiscal years 2021-2025, covering metrics like aggregate changes in pension values, grant-date fair values of equity and option awards, year-end fair values of unvested awards, year-over-year changes, vesting-date fair values, and forfeitures. No numerical values are provided in the excerpt, presenting a neutral disclosure without evident positive or negative trends.

• ·XBRL tags include pension adjustments, equity/stock awards grant-date fair values, option awards, year-end unvested values, YoY changes in prior awards, vesting values, and forfeiture values for PEO and Non-PEO NEOs.
• ·Fiscal periods covered: 2021, 2022, 2023, 2024, 2025.
• ·Currency specified: USD (iso4217:USD).

20-04-2026

Cibus, Inc. (CBUS) filed a DEF 14A Proxy Statement for its 2026 Annual Meeting of Stockholders, to be held virtually on June 2, 2026, at 10:00 a.m. PT, with a record date of April 6, 2026. Shareholders will vote to elect nine directors, approve on an advisory basis the compensation of Named Executive Officers, and ratify BDO USA, P.C. as independent registered public accounting firm for the year ending December 31, 2026. The filing references executive compensation elements for PEOs like Rory Riggs and Peter Beetham over periods including 2023-2025 but provides no specific financial metrics, growth rates, or period-over-period comparisons.

• ·Virtual meeting platform: www.virtualshareholdermeeting.com/CBUS2026
• ·Class A Common Stock par value: $0.0001 per share (full voting and economic rights)
• ·No Class B Common Stock outstanding
• ·Principal executive offices: 6455 Nancy Ridge Drive, San Diego, CA 92121

20-04-2026

Abercrombie & Fitch Co. reported record Fiscal 2025 net sales of $5.27 billion, up 6% from Fiscal 2024, driven by 15% growth in Hollister brands and a return to growth for Abercrombie brands in the fourth quarter, while achieving double-digit operating margins for the third consecutive year. The company generated $619 million in operating cash flow and returned $450 million to stockholders via share repurchases. This proxy statement for the June 3, 2026 virtual annual meeting seeks stockholder approval to elect nine directors, approve Fiscal 2025 named executive officer compensation on an advisory basis, and ratify PricewaterhouseCoopers LLP as independent auditor for Fiscal 2026.

• ·Record date: April 6, 2026
• ·Annual Meeting: June 3, 2026 at 10:00 a.m. Eastern Time via webcast at www.virtualshareholdermeeting.com/ANF2026
• ·Fiscal 2025 ended January 31, 2026

20-04-2026

PennyMac Financial Services, Inc. (PFSI) issued its 2026 Proxy Statement for the Annual Meeting on June 3, 2026, proposing the election of 10 experienced director nominees, ratification of the independent registered public accounting firm for the fiscal year ending December 31, 2026, and an advisory vote to approve named executive officer compensation. The Board emphasizes robust corporate governance features, including majority voting for uncontested director elections, an independent lead director (Jeffrey A. Perlowitz), annual board elections, and strict stock ownership guidelines, with no notable governance shortcomings highlighted. Director nominees possess deep expertise in mortgage finance, risk management, and leadership, supporting PFSI's focus on mortgage loan production, servicing, and investments.

• ·Annual Meeting Date and Time: Wednesday, June 3, 2026, at 11:00 a.m. Pacific Time, online via www.virtualshareholdermeeting.com/PFSI2026
• ·Record Date: April 6, 2026
• ·Proxy Statement Mail Date: April 20, 2026
• ·Independent Lead Director Term: Jeffrey A. Perlowitz, expires February 2028
• ·Board limits: CEO directors limited to 2 outside public boards; others to 5
• ·HCP nomination right: Up to 2 directors based on voting power ownership

20-04-2026

Charlie's Holdings, Inc. (CHUC) filed a DEF 14A Proxy Statement on April 20, 2026, for its annual meeting, detailing beneficial ownership of its 274,203,242 outstanding common shares and 93,906 Series A preferred shares (convertible into 21,195,576 common shares) as of April 10, 2026. Principal stockholders include Brandon Stump at 23.6%, Red Beard Holdings, LLC at 17.2%, and executive officers/directors/nominees as a group at 20.3%, with no significant changes or declines noted in ownership concentrations. The proxy seeks shareholder approval for the election of five current directors, including Ryan Stump, Scot Cohen, and Jeffrey Fox.

• ·Voting results for the Annual Meeting will be announced preliminarily at the meeting and released in a Form 8-K within four business days.
• ·No family relationships among directors or executive officers.
• ·Series A preferred stock subject to 4.99% (or 9.99% electable) ownership limitation and 9.99% voting limitation.

20-04-2026

InspireMD, Inc. (NSPR) filed a DEF 14A proxy statement dated April 20, 2026, for its annual stockholder meeting on June 3, 2026, seeking approval to elect three Class 3 directors (Marvin Slosman, Raymond Cohen, Dan Dearen), amend the Certificate of Incorporation to increase authorized common shares from 150,000,000 to 250,000,000, ratify Kesselman & Kesselman (PwC affiliate) as independent auditors for the year ending December 31, 2026, and approve potential adjournment for additional solicitation if needed. The board recommends voting FOR all proposals, with a record date of April 10, 2026. No financial performance metrics or period-over-period comparisons are detailed in the provided content.

• ·Annual meeting location: 4 Menorat Hamaor St., Tel-Aviv, Israel, at 10:00 a.m. Eastern Time on June 3, 2026.
• ·Principal executive office: 6303 Waterford District Drive, Suite 215, Miami, Florida 33126.
• ·Proxy materials available at www.proxyvote.com.
• ·Contact for attendance: mikel@inspiremd.com or (888) 776-6804.

20-04-2026

Cipher Mining Inc.'s DEF 14A proxy statement outlines the 2026 Annual Meeting agenda, including Proposal 1 to elect three Class II directors (Thomas Duda, James Newsome, Wesley Williams) for terms expiring in 2029, with Board size reducing from eight to seven following Holly Morrow Evans' departure. Proposal 2 seeks ratification of CBIZ CPAs P.C. as independent auditors for 2026, and Proposal 3 requests non-binding advisory approval of named executive officer compensation, with the Board recommending FOR votes on all. Voting must be completed by June 1, 2026, ahead of the virtual meeting.

• ·Annual Meeting voting deadline: June 1, 2026, 11:59 p.m. ET
• ·Proposal 1 requires plurality of votes cast; brokers cannot vote uninstructed shares
• ·Proposal 2 and 3 require majority of votes cast (abstentions and broker non-votes excluded)
• ·Thomas Duda (age 44, Director since 2026); James Newsome (age 66, since 2021); Wesley Williams (age 49, since 2021)
• ·Class I terms end 2028; Class III terms end 2027

20-04-2026

PTC Therapeutics, Inc. filed its DEF 14A proxy statement dated April 20, 2026, for the virtual 2026 Annual Meeting on June 2, 2026, at 9:00 a.m. ET. Stockholders will vote on electing four Class I director nominees for terms ending in 2029, ratifying Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026, and an advisory vote to approve named executive officer compensation. The record date is April 10, 2026, with 82,911,783 shares of common stock outstanding.

• ·Annual Meeting held virtually via live webcast at www.virtualshareholdermeeting.com/PTCT2026; no physical location.
• ·Proxy materials available on or about April 20, 2026; requests for printed copies due by May 19, 2026.
• ·Table of contents includes sections on corporate governance, executive compensation, director compensation, pay versus performance, and equity compensation plan information.

20-04-2026

Bristow Group Inc. (VTOL) has issued a proxy statement for its 2026 Annual Meeting of Stockholders on June 3, 2026, via live audio webcast, seeking approval to elect nine directors, approve on an advisory basis the named executive officer compensation, amend the 2021 Equity Incentive Plan to increase authorized shares from 3,385,000 to 4,200,000, and ratify KPMG LLP as independent auditors for 2026. The record date for voting eligibility is April 6, 2026. The proxy highlights compensation best practices including performance-based PSUs comprising 60% of long-term incentives and stock ownership requirements, with no significant changes from 2024.

• ·Meeting via webcast at www.virtualshareholdermeeting.com/VTOL2026 at 9:00 a.m. CDT.
• ·Proxy voting deadline: 11:59 p.m. EDT on June 2, 2026.
• ·Annual Report on Form 10-K referenced for year ended December 31, 2025.

20-04-2026

Horizon Kinetics Holding Corporation (HKHC) issued a DEF 14A proxy statement for its 2026 Annual Meeting on June 9, 2026, announcing the unexpected passing of co-founder Murray Stahl earlier in April 2026, a significant loss to the company he helped build since 1994. The Board recommends voting FOR director elections, ratification of CBIZ CPAs P.C. as auditor for the year ending December 31, 2026, and advisory approval of named executive officer compensation. The record date is April 24, 2026, with 18,635,321 shares of common stock outstanding.

• ·Annual Meeting hybrid format: virtual at www.virtualshareholdermeeting.com/HKHC2026 and in-person at 470 Park Avenue South, 3rd Floor, New York, New York 10016, on Tuesday, June 9, 2026, at 2:00 p.m. Eastern Time
• ·Proxy materials to be mailed on or about April 30, 2026
• ·Proposals 1 and 3 are non-routine (broker non-votes possible); Proposal 2 is routine

20-04-2026

OrthoPediatrics Corp (KIDS) filed a DEF 14A proxy statement dated April 20, 2026, for its annual stockholder meeting, seeking approval to elect four directors to serve until the 2029 annual meeting, advisory approval of named executive officer compensation, amendment to the 2024 Incentive Award Plan, and advisory ratification of Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026. As of the record date of April 6, 2026, 25,686,214 common shares were issued and outstanding, held by approximately 762 registered stockholders of record. The Board recommends voting FOR all proposals, with no other matters known to be presented.

• ·Record date: April 6, 2026
• ·Proxy voting deadline: 1:00 A.M. Eastern Time on June 4, 2026
• ·Annual Report on Form 10-K for fiscal year ended December 31, 2025 available on SEC website or company site
• ·Directors elected by plurality vote; other proposals by majority of votes cast

20-04-2026

CEVA INC filed its DEF 14A Proxy Statement on April 20, 2026, for the 2026 virtual annual shareholder meeting, with a record date of April 9, 2026, when 27,859,369 shares of common stock were outstanding. Proxy holders named are Amir Panush (CEO and board member), Yaniv Arieli (CFO), and Dotan Bar-Natan (Chief Legal Officer). The filing includes XBRL disclosures on equity compensation adjustments for PEOs and non-PEO NEOs across 2021-2025, with no specific financial performance metrics reported.

• ·Annual meeting held virtually at www.virtualshareholdermeeting.com/CEVA2026.
• ·Company address: 15245 Shady Grove Road, Suite 400, Rockville, Maryland 20850.
• ·References 2025 Form 10-K annual report available on www.ceva-ip.com and www.sec.gov.

20-04-2026

Open Lending Corporation's DEF 14A proxy statement for the 2026 virtual Annual Meeting of Stockholders seeks approval for electing two Class III directors, ratifying Ernst & Young LLP as independent auditors for FY 2026, advisory vote on named executive officer compensation, a stockholder proposal to declassify the board, and a reverse stock split. The record date is April 6, 2026, with 118,217,082 shares of common stock outstanding entitled to vote. No financial performance metrics are detailed, but the inclusion of a reverse stock split proposal may signal potential share price concerns.

• ·Record Date: April 6, 2026
• ·Proxy materials mailing: on or about April 20, 2026
• ·Annual Meeting: virtual format via live webcast
• ·Proposals: Election of two Class III directors; Ratification of Ernst & Young LLP for FY ending December 31, 2026; Advisory vote on NEO compensation; Stockholder proposal for board declassification; Reverse stock split
• ·Principal executive offices: 1501 S. MoPac Expressway, Suite 450, Austin, Texas 78746

20-04-2026

Dave Inc. filed its DEF 14A Proxy Statement on April 20, 2026, for the virtual Annual Meeting of Stockholders on June 2, 2026 at 9:00 a.m. PT, with a record date of April 13, 2026. Agenda items include electing one Class II director for a three-year term, advisory approval of 2025 executive compensation, an advisory vote on the frequency of future say-on-pay votes, and ratification of Deloitte & Touche LLP as independent auditors for the fiscal year ending December 31, 2026. Class A common stock carries 1 vote per share, while Class V common stock carries 10 votes per share, voting together as a single class.

• ·Proxy materials available at www.proxyvote.com prior to the meeting and www.virtualshareholdermeeting.com/DAVE2026 during the meeting.
• ·Stockholders need a 12-digit control number to attend the virtual meeting.
• ·Table of contents includes sections on director compensation, executive compensation (including 2025 Summary Compensation Table and Pay Versus Performance), security ownership, and related party transactions.

20-04-2026

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has issued a proxy statement for its virtual annual stockholder meeting on May 21, 2026 (record date March 25, 2026), seeking approval for electing five directors (including Interim CEO Christopher Cooper and Chairman George Scorsis), ratifying Forvis Mazars, LLP as independent auditor for FY 2026, advisory approval of executive compensation, authorizing a flexible reverse stock split (1-for-2 to 1-for-150 at Board's discretion), and potential meeting adjournment. The Board recommends voting FOR all proposals, highlighting governance practices like no stock option repricing without approval and no significant perquisites. No financial performance metrics are disclosed in the filing.

• ·Annual Meeting: Thursday, May 21, 2026 at 12:00 P.M. ET, virtual at www.virtualshareholdermeeting.com/SHPH2026
• ·Record date: March 25, 2026
• ·Reverse stock split: cumulative ratio 1-for-2 to 1-for-150, at Board's discretion
• ·Common stock listed on Nasdaq Capital Market (SHPH)
• ·Proxy materials mailed on or about April 20, 2026

20-04-2026

Entravision Communications Corporation's DEF 14A proxy statement, filed April 20, 2026, solicits votes for the virtual 2026 Annual Meeting on May 28, 2026, including electing seven directors, ratifying Deloitte & Touche LLP as independent auditors for FY 2026, advisory approval of named executive officer compensation, and amending the 2004 Equity Incentive Plan to authorize an additional 6,000,000 shares of Class A common stock. The record date is April 13, 2026, with 82,686,451 Class A shares outstanding entitled to vote. No financial performance metrics are detailed, focusing instead on standard governance proposals.

• ·Meeting held virtually only at 10:00 a.m. Pacific Daylight Time; no physical location.
• ·Quorum requires majority voting interest of Class A common stock.
• ·Brokers have discretionary voting authority only for auditor ratification (Proposal 2).

20-04-2026

KinderCare Learning Companies, Inc. (KLC) has issued its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on June 4, 2026, at 9:00 a.m. Pacific Time. Stockholders will vote on electing two Class II directors (term until 2029), one Class I director (term until 2028), ratifying PricewaterhouseCoopers LLP as independent auditors for fiscal 2026, and an advisory approval of named executive officer compensation. The record date is April 9, 2026, with 118,428,299 shares of common stock outstanding.

• ·Annual Meeting accessible at www.proxydocs.com/KLC; login from 8:45 a.m. PT.
• ·Record date: April 9, 2026; only stockholders of record entitled to vote.

20-04-2026

RadNet, Inc. (RDNT) filed its DEF 14A Definitive Proxy Statement on April 20, 2026, for the annual stockholders' meeting scheduled for June 2, 2026. The filing includes structured Pay vs. Performance disclosures for Principal Executive Officer Howard Berger and Non-PEO Named Executive Officers across fiscal years 2021-2025, covering elements such as equity awards, pension benefits, and adjustments. No specific compensation values or financial performance metrics are provided in the excerpt.

• ·Annual meeting date: June 2, 2026
• ·Fiscal years covered in Pay vs. Performance: 2021-2025
• ·Notice of Internet Availability mailed on or about April 20, 2026

20-04-2026

Landmark Bancorp Inc's DEF 14A proxy statement, filed April 20, 2026, seeks shareholder approval to elect three Class I directors—Angela S. Hurt, David H. Snapp, and Angelia K. Stanland—for terms expiring in 2029 at the upcoming annual meeting. Incumbent Class I director Sarah Hill-Nelson is retiring after 15 years of service, with no other significant changes to board composition noted. The filing includes XBRL disclosures on executive compensation elements for Michael E. Scheopner, Abigail M. Wendel, and non-PEO/NEOs across 2023-2025, but no numerical values are provided.

• ·Board has staggered three-year terms across three classes.
• ·Nominees serve on committees: Audit and Risk (Hurt, Kohlrus as Chair), Compensation (Stanland as Chair).
• ·Proxy solicitation costs borne by the company; no special compensation for officers/directors soliciting proxies.